Forskning ved Københavns Universitet - Københavns Universitet

Forside

NOVEL HYDROXAMIC ACIDS HAVING HISTONE DEACETYLASE INHIBITING ACTIVITY AND ANTI-CANCER COMPOSITION COMPRISING THE SAME AS AN ACTIVE INGREDIENT

Publikation: ForskningPatent

Truong Thanh Tung (Opfinder), HAN SANG BAE ; KIM YOUNG SOO ; HONG JIN TAE ; NGUYEN HAI NAM ; VAN THI MY HUE ; DAO THI KIM OANH (Opfinder)

The present invention relates to a pharmaceutical composition for anticancer including novel hydroxamic acid with histone deacetylase inhibiting activity as an active ingredient. Hydroxamic acid compound of the present invention has inhibitory activity of histone deacetylase (HDAC) and shows cytotoxicity to a variety of cancer cells, being useful in strong anti-cancer drug.
OriginalsprogEngelsk
IPCC07D277/44
Dato14/04/2014
LandSydkorea
StatusUdgivet - 31 dec. 2013

ID: 130699254